Statements (52)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:brand
gptkb:drug |
| gptkbp:activeIngredient |
botulinum toxin type A
|
| gptkbp:approvedBy |
gptkb:FDA
1989 |
| gptkbp:ATCCode |
M03AX01
|
| gptkbp:CASNumber |
93384-43-1
|
| gptkbp:chemicalClass |
gptkb:Dragon
|
| gptkbp:contraindication |
hypersensitivity to botulinum toxin
infection at injection site |
| gptkbp:discoveredBy |
gptkb:Alan_Scott
|
| gptkbp:effect |
3-6 months
|
| gptkbp:form |
powder for solution
|
| https://www.w3.org/2000/01/rdf-schema#label |
Botox
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Allergan
|
| gptkbp:marketedIn |
gptkb:Australia
gptkb:Canada gptkb:Europe gptkb:United_States |
| gptkbp:mechanismOfAction |
blocks acetylcholine release
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:relatedTo |
gptkb:Dysport
gptkb:Jeuveau gptkb:Xeomin |
| gptkbp:routeOfAdministration |
injection
|
| gptkbp:sideEffect |
headache
muscle weakness allergic reaction pain at injection site drooping eyelid |
| gptkbp:storage |
refrigerated
|
| gptkbp:usedFor |
treatment of spasticity
cosmetic procedures treatment of blepharospasm treatment of cervical dystonia treatment of chronic migraine treatment of crow's feet treatment of excessive sweating treatment of forehead lines treatment of frown lines treatment of glabellar lines treatment of lower limb spasticity treatment of muscle spasms treatment of overactive bladder treatment of sialorrhea treatment of strabismus treatment of upper limb spasticity treatment of urinary incontinence |
| gptkbp:bfsParent |
gptkb:Allergan
gptkb:Botulinum_toxin |
| gptkbp:bfsLayer |
6
|